Endotoxin-induced desensitization for mouse dermal vascular permeability.
内毒素诱导的小鼠真皮血管通透性脱敏。
基本信息
- 批准号:09672336
- 负责人:
- 金额:$ 1.86万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1998
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Subcutaneous injection of endotoxin (LPS) and some inflammatory mediators to mice increases the dye leakage at the site of injection indicating the increased dermal microvascular permeability. We investigated whether desensitization develops to the increase in permeability elicited by LPS or inflammatory mediators after systemic administration of a single low-dose LPS in male mice. Plasma extravasation was determined by Pontamine sky blue leakage at the site of the skin where LPS and mediators were injected s.c. The dye leakage *duced by LPS, 5-hydroxytryptamine (5-HT), platelet-activating factor, substance P or histamine was significantly decreased by 60-80% in LPS-primed mice, which indicates the development of homologous and heterologous tolerance. Pretreatment with tumor necrosis factor (TNF)-alpha and interleukin (IL)-lalpha but not IL-6 induced the tolerance to LPS, and anti-TNF-alpha antibody and anti-IL-1alpha antibody reversed the LPS-induced tolerance. Homologous tolerance disappeared in the adrenalectomized mice. When mice were pretreated with both LPS and N^G-nitro-L-arginine methyl ester, a nitric oxide (NO) synthase inhibitor, the hyporesponsiveness to LPS and 5-HT disappeared. These results suggest that endogenous cytokines, glucocorticoids and NO may play a role for development of LPS-induced tolerance in microcirculation. The tolerance induced by LPS may provide a potential basis for the treatment of septic shock.
给小鼠皮下注射内毒素(LPS)和一些炎症介质会增加注射部位的染料渗漏,表明真皮微血管通透性增加。我们研究了在雄性小鼠中全身施用单次低剂量 LPS 后,脱敏是否会发展为 LPS 或炎症介质引起的通透性增加。通过皮下注射 LPS 和介质的皮肤部位的 Pontamine 天蓝色渗漏来测定血浆外渗。在LPS引发的小鼠中,由LPS、5-羟色胺(5-HT)、血小板激活因子、P物质或组胺引起的染料渗漏显着减少60-80%,这表明同源和异源耐受性的发展。用肿瘤坏死因子(TNF)-α和白介素(IL)-1α而不是IL-6预处理诱导对LPS的耐受,并且抗TNF-α抗体和抗IL-1α抗体逆转了LPS诱导的耐受。同源耐受性在肾上腺切除小鼠中消失。当小鼠同时接受 LPS 和 N^G-硝基-L-精氨酸甲酯(一种一氧化氮 (NO) 合酶抑制剂)预处理时,对 LPS 和 5-HT 的低反应性消失了。这些结果表明,内源性细胞因子、糖皮质激素和 NO 可能在 LPS 诱导的微循环耐受性的发展中发挥作用。 LPS诱导的耐受可能为感染性休克的治疗提供潜在的基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Emiko FUJII: "Inhibittion by adenosine 3',5' cyclic monophosphate(cAMP) of lipopolysaccharide(LPS)-induced increase in mouse dermal microvascular permeability." Naunyn-Schmied Arch Pharmacol. 358(1) Suppl II. R737 (1998)
Emiko FUJII:“腺苷 3,5 环单磷酸 (cAMP) 抑制脂多糖 (LPS) 诱导的小鼠真皮微血管通透性增加。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Emiko FUJII: "Suppressive effects of phosphodiesterase(PDE) inhibitors and β-adrenoceptor agonists on the dermal vascular permeability change induced by lipopolysaccharide(LPS)in mice." Jpn.J.Pharmacol.76 Suppl I. 160p (1998)
Emiko FUJII:“磷酸二酯酶 (PDE) 抑制剂和 β-肾上腺素受体激动剂对脂多糖 (LPS) 诱导的小鼠真皮血管通透性变化的抑制作用。Jpn.J.Pharmacol.76 Suppl I. 160p (1998)”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Emiko FUJII: "Inducible nitric oxide synthase(iNOS)-deficient mice show altered dermal vascular permeability elicited by lipopolysaccharide." Jpn.J.Pharmacol.76 Suppl I. 62p (1998)
Emiko FUJII:“诱导型一氧化氮合酶 (iNOS) 缺陷小鼠表现出脂多糖引起的真皮血管通透性改变。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Emiko FUJII: "Inhibition by adenosine 3′, 5′ cyclic monophosphate (cAMP) of lipopolysaccharide (LPS)-induced increase in mouse dermal microvascular permeability." Naunyn-Schmied Arch Pharmacol. 358(1) Suppl II. R737 (1998)
Emiko FUJII:“脂多糖 (LPS) 诱导的腺苷 3, 5 环单磷酸 (cAMP) 抑制小鼠真皮微血管通透性增加。Naunyn-Schmied Arch Pharmacol 358(1) Suppl II。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FUJII Emiko其他文献
FUJII Emiko的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FUJII Emiko', 18)}}的其他基金
Prophylactic therapies to treat septic shock - Tolerance to LPS-induced microvascular change in mouse skin
治疗感染性休克的预防性疗法 - 对 LPS 诱导的小鼠皮肤微血管变化的耐受性
- 批准号:
13672401 - 财政年份:2001
- 资助金额:
$ 1.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Prophylactic therapies to treat septic shock - Study using vascular permeability in the skin of mice
治疗感染性休克的预防性疗法 - 利用小鼠皮肤血管通透性的研究
- 批准号:
11672279 - 财政年份:1999
- 资助金额:
$ 1.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似海外基金
Mechanisms of Endotoxin-induced Breakdown of Tolerance in the Lung
内毒素引起的肺耐受性破坏的机制
- 批准号:
8202694 - 财政年份:2011
- 资助金额:
$ 1.86万 - 项目类别:
Mechanisms of Endotoxin-induced Breakdown of Tolerance in the Lung
内毒素引起的肺耐受性破坏的机制
- 批准号:
8470485 - 财政年份:2011
- 资助金额:
$ 1.86万 - 项目类别:
Exploring the development of endotoxin tolerance in sepsis.
探索脓毒症内毒素耐受的发展。
- 批准号:
197323 - 财政年份:2009
- 资助金额:
$ 1.86万 - 项目类别:
Studentship Programs
A control methods of postoperative tumor progression using by endotoxin cross tolerance
一种利用内毒素交叉耐受控制术后肿瘤进展的方法
- 批准号:
15390372 - 财政年份:2003
- 资助金额:
$ 1.86万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Gfi1 in innate immunity: a downstream effector of Toll like receptor signaling and a novel regulator of endotoxin tolerance
先天免疫中的 Gfi1:Toll 样受体信号传导的下游效应器和内毒素耐受的新型调节剂
- 批准号:
5356844 - 财政年份:2002
- 资助金额:
$ 1.86万 - 项目类别:
Priority Programmes